Letters to the Editor

Lenalidomide, rituximab, and methotrexate are effective in newly diagnosed primary central nervous system lymphoma

Department of Hematology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, 310009
Department of Hematology, the Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, China, 310006
Department of Hematology, the Lishui Hospital, Zhejiang University School of Medicine, Lishui, China, 323000
Department of Hematology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, 310009
Department of Hematology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, 310009
Department of Hematology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, 310009
Department of Hematology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, 310009
Department of Hematology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, 310009; National Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Suzhou, China, 215123
Haematologica Early view Feb 15, 2024 https://doi.org/10.3324/haematol.2023.284834